Search
The benefits and challenges of technology-based health care. Enhancing the recruitment and retention of new nurses into long-term care. The importance of patients' and caregivers' voices in improving care outcomes and influencing health policy. New...
Novel research at Kingston General Hospital targeting C. difficile has been awarded major funding from the U.S. National Institutes of Health. The funding, of up to $1.2 million, will enable a multi-institutional team led by Elaine Petrof, a...
Every few years a new piece of technology is released that can dramatically change the way medical teams provide care to their patients. Now, Canadian surgeons and researchers have partnered with a team in the U.K. to develop a tool that will...
Researchers at Kingston Health Sciences Centre and Queen's University have published the first set of findings stemming from the Kingston Allergy Birth Cohort - a study that tracks the origins of allergies in nearly 400 mother-child pairs from pre...
A joint research team at the Kingston General Hospital Research Institute and the Ottawa Hospital Research Institute have been awarded $9.8 million from the Canadian Institutes of Health Research to continue their groundbreaking work into maternal...
A new mobile phone app has been launched in Kingston with a goal of saving the lives of people who experience cardiac arrest outside of the hospital. Kingston is the first community in Canada to introduce PulsePoint - a free app that is already...
New technology in the KGH Research Institute's W.J. Henderson Centre for Patient-Oriented Research is helping scientists accelerate their search for the causes of bowel disorders such as irritable bowel syndrome (IBS). Mass spectrometry equipment has...
A new approach to treating grass allergies offers potential as a shorter and more effective alternative to traditional allergen immunotherapy (a.k.a. "allergy shots"), a study led by KGHRI clinician scientist Dr. Anne Ellis has shown. It was the...
One of the greatest unmet needs of patients with inflammatory bowel disease (IBD) is abdominal pain. Opioid drugs are the most effective treatment, but they have serious side effects. However, new opioid drugs now in development offer longer-lasting...
FOR IMMEDIATE RELEASE Monday, Sept. 28, 2020 KINGSTON, Ont. - Queen's University announced that it has entered into a research collaboration and licensing agreement with Taysha Gene Therapies, Inc., for the development and commercialization of gene...
